Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Tangney

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Current Gene Therapy|February 22, 2012
Editorial: in vivo imaging & gene therapyMark Tangney
Discovery Medicine|September 30, 2010
Gene therapy for cancer: dairy bacteria as delivery vectorsMark Tangney
Infectious Agents and Cancer|March 30, 2013
Bacteria and tumours: causative agents or opportunistic inhabitants?Joanne Cummins, Mark Tangney
Trends in Pharmacological Sciences|September 11, 2018
The Who, What, and Why of Drug Discovery and DevelopmentGlenn Hogan, Mark Tangney
Microbiome Research Reports|April 10, 2025
The oncobiome; what, so what, now what?Munawar Abbas, Mark Tangney
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 2025
Bacterial exopolysaccharides and live biotherapeutics: Orchestrating immune modulation and therapeutic potential in the gut microbiome eraArpit Shukla, Mark Tangney
FEMS Microbiology Letters|May 23, 2002
Effectiveness of the lactococcal abortive infection systems AbiA, AbiE, AbiF and AbiG against P335 type phagesMark Tangney, Gerald F Fitzgerald
Applied and Environmental Microbiology|November 27, 2002
AbiA, a lactococcal abortive infection mechanism functioning in Streptococcus thermophilusMark Tangney, Gerald F Fitzgerald
Trends in Biotechnology|March 3, 2017
Synthetic Biology in the Driving Seat of the BioeconomyYensi Flores Bueso, Mark Tangney
Cancers|March 13, 2025
Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer ImmunotherapyGabriela Christina Kuhl, Mark Tangney
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Current Gene Therapy|February 22, 2012
Editorial: in vivo imaging & gene therapyMark Tangney
Discovery Medicine|September 30, 2010
Gene therapy for cancer: dairy bacteria as delivery vectorsMark Tangney
Infectious Agents and Cancer|March 30, 2013
Bacteria and tumours: causative agents or opportunistic inhabitants?Joanne Cummins, Mark Tangney
Trends in Pharmacological Sciences|September 11, 2018
The Who, What, and Why of Drug Discovery and DevelopmentGlenn Hogan, Mark Tangney
Microbiome Research Reports|April 10, 2025
The oncobiome; what, so what, now what?Munawar Abbas, Mark Tangney
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 3, 2025
Bacterial exopolysaccharides and live biotherapeutics: Orchestrating immune modulation and therapeutic potential in the gut microbiome eraArpit Shukla, Mark Tangney
FEMS Microbiology Letters|May 23, 2002
Effectiveness of the lactococcal abortive infection systems AbiA, AbiE, AbiF and AbiG against P335 type phagesMark Tangney, Gerald F Fitzgerald
Applied and Environmental Microbiology|November 27, 2002
AbiA, a lactococcal abortive infection mechanism functioning in Streptococcus thermophilusMark Tangney, Gerald F Fitzgerald
Trends in Biotechnology|March 3, 2017
Synthetic Biology in the Driving Seat of the BioeconomyYensi Flores Bueso, Mark Tangney
Cancers|March 13, 2025
Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer ImmunotherapyGabriela Christina Kuhl, Mark Tangney
Pageof 9